Nanomedicine in the Treatment of Metabolic Disorders

Abstract

Nanomedicine, the application of nanotechnology in medicine, has shown remarkable potential in the diagnosis, monitoring, and treatment of metabolic disorders such as diabetes, obesity, and hyperlipidemia. By enabling targeted drug delivery, enhancing bioavailability, and reducing systemic side effects, nanocarriers offer superior therapeutic efficacy compared to conventional modalities. This paper explores the types of nanostructures employed, mechanisms of action, and clinical advancements in using nanomedicine to treat metabolic conditions. Additionally, challenges and future directions are discussed to underscore the need for further translational research.